Mylan CEO defends EpiPen prices

4 months ago Comments Off on Mylan CEO defends EpiPen prices

The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens and signaling the company has no plans to lower prices despite a public outcry.
Stock quotes, financial tools, news and analysis – MSN Money